← Leaderboards
Yaping Tu
University Of Nebraska Medical Center
$5,176,736
Attributed
$5,176,736
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $581.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,176,736 · 8
By mechanism
R01$3,920,430 · 3
R21$765,590 · 2
P20$490,716 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Maneesh Jain$6,905,007
- Ravi Salgia$9,622,551
- Bryan K Becker$826,776
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionRegulationIn VivoInhibitor/AntagonistPlaySignal PathwayOverexpressionMutantDown-RegulationMolecularResponseRepressionAnimal ModelCell ModelMolecular ModelingCellsMediatingPharmaceutical PreparationsExtrinsic AsthmaMemberCytokineAttenuatedFunctional DisorderAirway Hyperresponsiveness
Grant awards (19)
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.$429,311
R01 · FY2025 · HL · contact PI
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.$422,893
R01 · FY2024 · HL · contact PI
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.$411,112
R01 · FY2023 · HL · contact PI
Neuronal P-Rex1 repression: a key factor in early-life environmental cigarette smoke exposure mediated risk of asthma$181,875
R21 · FY2020 · ES · contact PI
Neuronal P-Rex1 repression: a key factor in early-life environmental cigarette smoke exposure mediated risk of asthma$218,250
R21 · FY2019 · ES · contact PI
Androgen Receptor: A Key Regulator of TRAIL Resistance in Breast Cancer?$160,950
R21 · FY2017 · CA · contact PI
Dysregulation of RGS2 Protein and Airway Hyperresponsiveness in Asthma$363,750
R01 · FY2016 · HL · contact PI
Androgen Receptor: A Key Regulator of TRAIL Resistance in Breast Cancer?$204,515
R21 · FY2016 · CA · contact PI
Dysregulation of RGS2 Protein and Airway Hyperresponsiveness in Asthma$358,293
R01 · FY2015 · HL · contact PI
Dysregulation of RGS2 Protein and Airway Hyperresponsiveness in Asthma$356,475
R01 · FY2014 · HL · contact PI
Dysregulation of RGS2 Protein and Airway Hyperresponsiveness in Asthma$346,290
R01 · FY2013 · HL · contact PI
Regulator of G-protein Signaling (RGS) Proteins in Prostate Cancer$238,408
R01 · FY2011 · CA · contact PI
Regulator of G-protein Signaling (RGS) Proteins in Prostate Cancer$245,770
R01 · FY2010 · CA · contact PI
Regulator of G-protein Signaling (RGS) Proteins in Prostate Cancer$245,761
R01 · FY2009 · CA · contact PI
Regulator of G-protein Signaling (RGS) Proteins in Prostate Cancer$250,118
R01 · FY2008 · CA · contact PI
COBRE; CREIGHTON UNIV; P10; PROSTATE CANCER: THE ROLE OF G-PROTEIN ALPHA12$329,229
P20 · FY2007 · RR · contact PI
Regulator of G-protein Signaling (RGS) Proteins in Prostate Cancer$252,249
R01 · FY2007 · CA · contact PI
COBRE; CREIGHTON UNIV; PILOT 1; PROSTATE CANCER: THE ROLE OF G-PROTEIN ALPHA12$66,339
P20 · FY2006 · RR · contact PI
COBRE;CREIGHTON UNIV;PILOT 1;PROSTATE CANCER: THE ROLE OF G-PROTEIN ALPHA12$95,148
P20 · FY2005 · RR